Table Of Content

International Journal of Pharmaceutics, 79 (1992) 309-311 © 1992 Elsevier Science Publishers B.V. All rights reserved 0378-/5921 /7$053.0 0 Author Index Albers, E., see Miller, B.W. (79) 273 Del Olmo Fernandez, E., see Toth, I. (79) 39 Aldén, M., see Sjékvist, E. (79) 123 Dumont, P., see Mbela, T.K.M. (79) 29 Anguiano-lIgea, S., see Otero-Espinar, F.J. (79) 149 Athanasiou, A., see Avgoustakis, K. (79) 67 Engstrom, L., see Engstrom, S. (79) 113 Auriola, S., see Jarvinen, T. (79) 233 Engstrom, S. and Engstrom, L. Avgoustakis, K., Athanasiou, A. and Georgakopoulos, P.P. Phase behaviour of the lidocaine-monoolein-water system Effect of helix characteristics on the dissolution rate of (79) 113 hard gelatin capsules (79) 67 Estes, K.S., see Brewster, M.E. (79) 289 Feijen, J., see Kwon, G.S. (79) 191 Bae, Y.H., see Kwon, G.S. (79) 191 Fernandez, B., Mosquera, R. and Uriarte, E. Baldvinsd6ttir, J., see Loftsson, T. (79) 107 Structure-activity relationships in verapamil and analogues Baldwin, R.W., see Pimm, M.V. (79) 77 using molecular mechanics calculations (79) 199 Banker, G.S., see Kumar, V. (79) 61 Fielden, K.E., Newton, J.M. and Rowe, R.C. Behari, J.-R. and Gregoriadis, G. Movement of liquids through powder beds (79) 47 A comparative study of free and liposome-entrapped di- Fridriksdottir, H., see Brewster, M.E. (79) 289 ethylenetriaminepentaacetic acid used in the treatment of mice loaded with cadmium (79) 213 Garcia-Gonzalez, N., see Otero-Espinar, F.J. (79) 149 Bermejo, M.V., see Garrigues, T.M. (79) 135 Bhattachar, S.N., Rytting, J.H., Itoh, T. and Nishihata, T. Garrigues, T.M., Pérez-Varona, A.T., Bermejo, M.V. and Martin-Villodre, A. The effects of complexation with hydrogenated phospho- Absorption-partition relationships for true homologous se- lipid on the transport of salicylic acid, diclofenac and ries of xenobiotics as a possible approach to study mecha- indomethacin across snake stratum corneum (79) 263 nisms of surfactants in absorption. IV. Phenylacetic acid Blanco-Méndez, J., see Otero-Espinar, F.J. (79) 149 Bodor, N., see Brewster, M.E. (79) 289 derivatives and anionic surfactants (79) 135 Georgakopoulos, P.P., see Avgoustakis, K. (79) 67 Bouwstra, J.A., Gooris, G.S., Brussee, J., Salomons-de Vries, Gibbons, W.A., see Toth, I. (79) 39 M.A. and Bras, W. Gooris, G.S., see Bouwstra, J.A. (79) 141 The influence of alkyl-azones on the ordering of the Gordon, J.D. and Chow, A.H.L. lamellae in human stratum corneum (79) 141 Modification of phenytoin crystals. II. Influence of 3-pro- Bras, W., see Bouwstra, J.A. (79) 141 panoyloxymethyl-5,5-diphenylhydantoin on solution-phase Brewster, M.E., Loftsson, T., Estes, K.S., Lin, J.-L., crystallization and related crystal properties (79) 171 Fridriksdottir, H. and Bodor, N. Gregoriadis, G., see Behari, J.-R. (79) 213 Effect of various cyclodextrins on solution stability and Griffith, I.P., see Toth, I. (79) 39 dissolution rate of doxorubicin hydrochloride (79) 289 Gutiérrez, F., see Veiga, M. (79) 1 Brussee, J., see Bouwstra, J.A. (79) 141 Bundgaard, H., see Hansen, K.T. (79) 205 Hafeez, R.A., see Toth, I. (79) 39 Hansen, K.T., Jansen, J.A., Mengel, H., Christensen, J.V. and Caram-Lelham, N., see Sjdkvist, E. (79) 123 Bundgaard, H. Chang, H.W., Lee, M.G., Lee, H., Park, M.K. and Kim, C.-K. Enhanced bioavailability of a new class of dopamine D-1 Effects of leucovorin on the pharmacokinetics of antagonists following oral administration of their carbamic methotrexate in rabbits (79) 71 acid ester prodrugs to dogs (79) 205 Chow, A.H.L., see Gordon, J.D. (79) 171 Hatanaka, T., Inuma, M., Sugibayashi, K. and Morimoto, Y. Christensen, J.V., see Hansen, K.T. (79) 205 Prediction of skin permeability of drugs. II. Development Clegg, J.A., see Pimm, M.V. (79) 77 of composite membrane as a skin alternative (79) 21 Cremers, H., see Kwon, G.S. (79) 191 Hermecz, I., see Takacs-Novak, K. (79) 89 310 Holley, J.L., see Toth, I. (79) 39 saccharides as new absorption enhancers in rat rectum Hudecz, F., see Pimm, M.V. (79) 77 (79) 159 Muranishi, S., see Murakami, M. (79) 159 Inuma, M., see Hatanaka, T. (79) 21 Newton, J.M., see Fielden, K.E. (79) 47 Itoh, T., see Bhattachar, S.N. (79) 263 Nishihata, T., see Bhattachar, S.N. (79) 263 lula, A.K., see Won, C.M. (79) 183 Nystrom, C., see SjOkvist, E. (79) 123 Jansen, J.A., see Hansen, K.T. (79) 205 Olafsdéttir, B.J., see Loftsson, T. (79) 107 Jarvinen, T., Suhonen, P., Auriola, S., Vepsalainen, J., Urtti, Otero-Espinar, F.J., Anguiano-Igea, $., Garcia-Gonzalez, N., A. and Peura, P. Vila-Jato, J.L. and Blanco-Méndez, J. Bispilocarpic acid monoesters as prodrugs of pilocarpine: Interaction of naproxen with B-cyclodextrin in solution I. Preparation and identification (79) 233 and in the solid state (79) 149 Jarvinen, T., Suhonen, P., Urtti, A. and Peura, P. Bispilocarpic acid monoesters as prodrugs of pilocarpine: Park, M.K., see Chang, H.W. (79) 71 II. Physicochemical properties and kinetics of hydrolysis in Pérez-Varona, A.T., see Garrigues, T.M. (79) 135 aqueous solution (79) 243 Peura, P., see Jarvinen, T. (79) 233 Johansson, M.O., see Ragnarsson, G. (79) 223 Peura, P., see Jarvinen, T. (79) 243 Jézan, M., see Takacs-Novak, K. (79) 89 Pimm, M.V., Clegg, J.A., Hudecz, F. and Baldwin, R.W. 'llTn labelling of a branched polypeptide drug carrier with Kim, C.-K. and Lee, E.-J. a poly(L-lysine) backbone (79) 77 The controlled release of blue dextran from alginate beads Poupaert, J.H., see Mbela, T.K.M. (79) 29 (79) 11 Kim, C.-K., see Chang, H.W. (79) 71 Ragnarsson, G., Sandberg, A., Johansson, M.O., Lindstedt, B. Kim, S.W., see Kwon, G.S. (79) 191 and Sjogren, J. Kumar, V. and Banker, G.S. In vitro release characteristics of a membrane-coated pel- Incompatibility of polyvinyl acetate phthalate with benzo- let formulation — influence of drug solubility and particle caine: Isolation and characterization of 4-phthalimido- size (79) 223 benzoic acid ethyl ester (79) 61 Razdan, B. and Verma, P.K. Kusanoi, Y., see Murakami, M. (79) 159 Evaluation of dosage forms. III: Studies on commercial Kwon, G.S., Bae, Y.H., Cremers, H., Feijen, J. and Kim, S.W. acetaminophen tablet dosage forms (79) 83 Release of macromolecules from albumin-heparin micro- Rowe, R.C. spheres (79) 191 Calorimetric studies on some nonionic surfactants (79) 251 Rowe, R.C. Lee, E.-J., see Kim, C.-K. (79) 11 Interactions in powders and granules — a reappraisal (79) Lee, H., see Chang, H.W. (79) 71 257 Lee, M.G., see Chang, H.W. (79) 71 Rowe, R.C., see Fielden, K.E. (79) 47 Lin, J.-L., see Brewster, M.E. (79) 289 Rytting, J.H., see Bhattachar, S.N. (79) 263 Lindstedt, B., see Ragnarsson, G. (79) 223 Loftsson, T., Olafsdéttir, B.J. and Baldvinsdéttir, J. Salomons-de Vries, M.A., see Bouwstra, J.A. (79) 141 Estramustine: hydrolysis, solubilization, and stabilization Sam, A.P., Van den Heuij, J.T.M. and Tukker, J.J. in aqueous solutions (79) 107 Mucoadhesion of both film-forming and non-film-forming Loftsson, T., see Brewster, M.E. (79) 289 polymeric materials as evaluated with the Wilhelmy plate method (79) 97 Martin-Villodre, A., see Garrigues, T.M. (79) 135 Sandberg, A., see Ragnarsson, G. (79) 223 Mbela, T.K.M., Poupaert, J.H. and Dumont, P. Sjogren, J., see Ragnarsson, G. (79) 223 Poly(diethylmethylidene malonate) nanoparticles as _pri- SjOkvist, E., Nystrom, C., Aldén, M. and Caram-Lelham, N. maquine delivery system to liver (79) 29 Physicochemical aspects of drug release. XIV. The effects Mengel, H., see Hansen, K.T. (79) 205 of some ionic and non-ionic surfactants on properties of a Morimoto, Y., see Hatanaka, T. (79) 21 sparingly soluble drug in solid dispersions (79) 123 Mosquera, R., see Fernandez, B. (79) 199 Sugibayashi, K., see Hatanaka, T. (79) 21 Muller, B.W. and Albers, E. Suhonen, P., see Jarvinen, T. (79) 233 Complexation of dihydropyridine derivatives with cy- Suhonen, P., see Jarvinen, T. (79) 243 clodextrins and 2-hydroxypropyl-B-cyclodextrin in solution Szasz, G., see Takacs-Novak, K. (79) 89 (79) 273 Murakami, M., Kusanoi, Y., Takada, K. and Muranishi, S. Takacs-Novak, K., J6zan, M., Hermecz, I. and Szasz, G. Assessment of enhancing ability of medium-chain alkyl Lipophilicity of antibacterial fluoroquinolones (79) 89 Takada, K., see Murakami, M. (79) 159 Vepsalainen, J., see Jarvinen, T. (79) 233 Toth, I., Griffith, 1.P., Del Olmo Fernandez, E., Hafeez, R.A., Verma, P.K., see Razdan, B. (79) 83 Holley, J.L., Ward, P. and Gibbons, W.A. Vila-Jato, J.L., see Otero-Espinar, F.J. (79) 149 Lipidic peptides. VIII. Cellular uptake studies of lipidic Vromans, H. and Van Laarhoven, J.A.H. amino acid, its oligomers and highly lipophilic drug conju- A study on water permeation through rubber closures of gates (79) 39 injection vials (79) 301 Tukker, J.J., see Sam, A.P. (79) 97 Uriarte, E., see Fernandez, B. (79) 199 Ward, P., see Toth, I. (79) 39 Urtti, A., see Jarvinen, T. (79) 233 Won, C.M. and Iula, A.K. Urtti, A., see Jarvinen, T. (79) 243 Kinetics of hydrolysis of diltiazem (79) 183 Van den Heuij, J.T.M., see Sam, A.P. (79) 97 Van Laarhoven, J.A.H., see Vromans, H. (79) 301 Veiga, M. and Gutiérrez, F. Yamamura, K. and Yotsuyanagi, T. Mathematical transformation of data, fit, and graphic rep- Adsorption and irreversible binding of adriamycin incor- resentation of regression curves through computer pro- porated into hydroxyapatite beads (79) R1 gramming (79) 1 Yotsuyanagi, T., see Yamamura, K. (79) R1